nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B3—Liothyronine—hypothyroidism	0.142	0.165	CbGbCtD
Pioglitazone—SLCO1B3—Levothyroxine—hypothyroidism	0.142	0.165	CbGbCtD
Pioglitazone—SLCO1B3—Liotrix—hypothyroidism	0.138	0.161	CbGbCtD
Pioglitazone—SLCO1B1—Dextrothyroxine—hypothyroidism	0.109	0.127	CbGbCtD
Pioglitazone—SLCO1B1—Levothyroxine—hypothyroidism	0.0825	0.096	CbGbCtD
Pioglitazone—SLCO1B1—Liothyronine—hypothyroidism	0.0825	0.096	CbGbCtD
Pioglitazone—SLCO1B1—Liotrix—hypothyroidism	0.0805	0.0937	CbGbCtD
Pioglitazone—CYP2C8—Levothyroxine—hypothyroidism	0.0349	0.0406	CbGbCtD
Pioglitazone—CYP2C8—Liotrix—hypothyroidism	0.0341	0.0397	CbGbCtD
Pioglitazone—CYP3A4—Levothyroxine—hypothyroidism	0.0142	0.0165	CbGbCtD
Pioglitazone—PPARG—brown adipose tissue—hypothyroidism	0.00671	0.174	CbGeAlD
Pioglitazone—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00412	0.0451	CcSEcCtD
Pioglitazone—CYP2C19—urine—hypothyroidism	0.00321	0.0832	CbGeAlD
Pioglitazone—Angina pectoris—Liothyronine—hypothyroidism	0.00314	0.0344	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00284	0.0311	CcSEcCtD
Pioglitazone—Myocardial infarction—Liothyronine—hypothyroidism	0.00282	0.0309	CcSEcCtD
Pioglitazone—CYP2C9—urine—hypothyroidism	0.00249	0.0645	CbGeAlD
Pioglitazone—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00202	0.0222	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00202	0.0222	CcSEcCtD
Pioglitazone—Increased appetite—Dextrothyroxine—hypothyroidism	0.00195	0.0214	CcSEcCtD
Pioglitazone—Increased appetite—Levothyroxine—hypothyroidism	0.00195	0.0214	CcSEcCtD
Pioglitazone—Hypertension—Liothyronine—hypothyroidism	0.00194	0.0213	CcSEcCtD
Pioglitazone—CYP3A4—urine—hypothyroidism	0.0019	0.0492	CbGeAlD
Pioglitazone—Cardiac failure—Levothyroxine—hypothyroidism	0.00188	0.0206	CcSEcCtD
Pioglitazone—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00188	0.0206	CcSEcCtD
Pioglitazone—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00188	0.0206	CcSEcCtD
Pioglitazone—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00188	0.0206	CcSEcCtD
Pioglitazone—CYP2D6—urine—hypothyroidism	0.00187	0.0484	CbGeAlD
Pioglitazone—SLCO1B3—pituitary gland—hypothyroidism	0.00182	0.0473	CbGeAlD
Pioglitazone—Fluid retention—Liotrix—hypothyroidism	0.00176	0.0193	CcSEcCtD
Pioglitazone—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00154	0.0169	CcSEcCtD
Pioglitazone—Angina pectoris—Levothyroxine—hypothyroidism	0.00154	0.0169	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Liotrix—hypothyroidism	0.00149	0.0163	CcSEcCtD
Pioglitazone—Increased appetite—Liotrix—hypothyroidism	0.00144	0.0157	CcSEcCtD
Pioglitazone—Weight decreased—Dextrothyroxine—hypothyroidism	0.00143	0.0157	CcSEcCtD
Pioglitazone—Weight decreased—Levothyroxine—hypothyroidism	0.00143	0.0157	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00139	0.0153	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00139	0.0153	CcSEcCtD
Pioglitazone—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00138	0.0152	CcSEcCtD
Pioglitazone—Myocardial infarction—Levothyroxine—hypothyroidism	0.00138	0.0152	CcSEcCtD
Pioglitazone—Hypoglycaemia—Liotrix—hypothyroidism	0.00138	0.0151	CcSEcCtD
Pioglitazone—Cardiac failure—Liotrix—hypothyroidism	0.00138	0.0151	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Liotrix—hypothyroidism	0.00138	0.0151	CcSEcCtD
Pioglitazone—Sweating—Levothyroxine—hypothyroidism	0.00135	0.0148	CcSEcCtD
Pioglitazone—Sweating—Dextrothyroxine—hypothyroidism	0.00135	0.0148	CcSEcCtD
Pioglitazone—SLCO1B3—liver—hypothyroidism	0.00127	0.033	CbGeAlD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.00126	0.111	CbGpPWpGaD
Pioglitazone—Angina pectoris—Liotrix—hypothyroidism	0.00114	0.0124	CcSEcCtD
Pioglitazone—Bronchitis—Liotrix—hypothyroidism	0.00112	0.0123	CcSEcCtD
Pioglitazone—PPARG—heart—hypothyroidism	0.00109	0.0282	CbGeAlD
Pioglitazone—Weight decreased—Liotrix—hypothyroidism	0.00105	0.0116	CcSEcCtD
Pioglitazone—PPARG—cardiovascular system—hypothyroidism	0.00103	0.0266	CbGeAlD
Pioglitazone—Acute coronary syndrome—Liotrix—hypothyroidism	0.00102	0.0112	CcSEcCtD
Pioglitazone—Myocardial infarction—Liotrix—hypothyroidism	0.00102	0.0112	CcSEcCtD
Pioglitazone—Angioedema—Dextrothyroxine—hypothyroidism	0.00101	0.0111	CcSEcCtD
Pioglitazone—Angioedema—Levothyroxine—hypothyroidism	0.00101	0.0111	CcSEcCtD
Pioglitazone—Sweating—Liotrix—hypothyroidism	0.000996	0.0109	CcSEcCtD
Pioglitazone—SLCO1B1—blood—hypothyroidism	0.000942	0.0244	CbGeAlD
Pioglitazone—Arthralgia—Levothyroxine—hypothyroidism	0.00094	0.0103	CcSEcCtD
Pioglitazone—Arthralgia—Dextrothyroxine—hypothyroidism	0.00094	0.0103	CcSEcCtD
Pioglitazone—Hypoaesthesia—Liotrix—hypothyroidism	0.000928	0.0102	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptors—THRA—hypothyroidism	0.000928	0.082	CbGpPWpGaD
Pioglitazone—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000871	0.00955	CcSEcCtD
Pioglitazone—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000871	0.00955	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000821	0.009	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000821	0.009	CcSEcCtD
Pioglitazone—Insomnia—Levothyroxine—hypothyroidism	0.000815	0.00893	CcSEcCtD
Pioglitazone—Insomnia—Dextrothyroxine—hypothyroidism	0.000815	0.00893	CcSEcCtD
Pioglitazone—PPARG—adrenal gland—hypothyroidism	0.000813	0.0211	CbGeAlD
Pioglitazone—PPARG—blood—hypothyroidism	0.000813	0.0211	CbGeAlD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00081	0.0716	CbGpPWpGaD
Pioglitazone—Dyspnoea—Levothyroxine—hypothyroidism	0.000803	0.0088	CcSEcCtD
Pioglitazone—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000803	0.0088	CcSEcCtD
Pioglitazone—Flatulence—Liotrix—hypothyroidism	0.0008	0.00877	CcSEcCtD
Pioglitazone—PPARG—thyroid gland—hypothyroidism	0.000784	0.0203	CbGeAlD
Pioglitazone—Fatigue—Levothyroxine—hypothyroidism	0.000777	0.00851	CcSEcCtD
Pioglitazone—Fatigue—Dextrothyroxine—hypothyroidism	0.000777	0.00851	CcSEcCtD
Pioglitazone—PPARG—female gonad—hypothyroidism	0.000758	0.0196	CbGeAlD
Pioglitazone—SLCO1B3—Transport of organic anions—AVP—hypothyroidism	0.000752	0.0665	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000742	0.00814	CcSEcCtD
Pioglitazone—Feeling abnormal—Levothyroxine—hypothyroidism	0.000742	0.00814	CcSEcCtD
Pioglitazone—Angioedema—Liotrix—hypothyroidism	0.000742	0.00813	CcSEcCtD
Pioglitazone—SLCO1B1—liver—hypothyroidism	0.000737	0.0191	CbGeAlD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.000733	0.0648	CbGpPWpGaD
Pioglitazone—Urticaria—Dextrothyroxine—hypothyroidism	0.000716	0.00784	CcSEcCtD
Pioglitazone—Urticaria—Levothyroxine—hypothyroidism	0.000716	0.00784	CcSEcCtD
Pioglitazone—Hypertension—Liotrix—hypothyroidism	0.000701	0.00768	CcSEcCtD
Pioglitazone—Chest pain—Liotrix—hypothyroidism	0.000691	0.00758	CcSEcCtD
Pioglitazone—Arthralgia—Liotrix—hypothyroidism	0.000691	0.00758	CcSEcCtD
Pioglitazone—PPARG—testis—hypothyroidism	0.000672	0.0174	CbGeAlD
Pioglitazone—Anaphylactic shock—Liotrix—hypothyroidism	0.000663	0.00726	CcSEcCtD
Pioglitazone—Oedema—Liotrix—hypothyroidism	0.000663	0.00726	CcSEcCtD
Pioglitazone—Infection—Liotrix—hypothyroidism	0.000658	0.00722	CcSEcCtD
Pioglitazone—Asthenia—Levothyroxine—hypothyroidism	0.000646	0.00708	CcSEcCtD
Pioglitazone—Asthenia—Dextrothyroxine—hypothyroidism	0.000646	0.00708	CcSEcCtD
Pioglitazone—Hyperhidrosis—Liotrix—hypothyroidism	0.000641	0.00702	CcSEcCtD
Pioglitazone—CYP2C9—heart—hypothyroidism	0.000638	0.0165	CbGeAlD
Pioglitazone—PPARG—liver—hypothyroidism	0.000635	0.0165	CbGeAlD
Pioglitazone—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000616	0.00676	CcSEcCtD
Pioglitazone—Diarrhoea—Levothyroxine—hypothyroidism	0.000616	0.00676	CcSEcCtD
Pioglitazone—CYP2C19—blood—hypothyroidism	0.000614	0.0159	CbGeAlD
Pioglitazone—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000604	0.00662	CcSEcCtD
Pioglitazone—CYP2C9—cardiovascular system—hypothyroidism	0.000602	0.0156	CbGeAlD
Pioglitazone—CYP2C8—pituitary gland—hypothyroidism	0.0006	0.0155	CbGeAlD
Pioglitazone—Insomnia—Liotrix—hypothyroidism	0.000599	0.00657	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptors—THRB—hypothyroidism	0.000598	0.0528	CbGpPWpGaD
Pioglitazone—Dyspnoea—Liotrix—hypothyroidism	0.000591	0.00648	CcSEcCtD
Pioglitazone—PTGS1—heart—hypothyroidism	0.000582	0.0151	CbGeAlD
Pioglitazone—Fatigue—Liotrix—hypothyroidism	0.000571	0.00626	CcSEcCtD
Pioglitazone—Headache—Dextrothyroxine—hypothyroidism	0.000564	0.00619	CcSEcCtD
Pioglitazone—Headache—Levothyroxine—hypothyroidism	0.000564	0.00619	CcSEcCtD
Pioglitazone—PTGS1—cardiovascular system—hypothyroidism	0.000549	0.0142	CbGeAlD
Pioglitazone—Feeling abnormal—Liotrix—hypothyroidism	0.000546	0.00599	CcSEcCtD
Pioglitazone—CYP2C8—blood—hypothyroidism	0.000536	0.0139	CbGeAlD
Pioglitazone—Urticaria—Liotrix—hypothyroidism	0.000526	0.00577	CcSEcCtD
Pioglitazone—SLCO1B1—Transport of organic anions—AVP—hypothyroidism	0.000505	0.0447	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Liotrix—hypothyroidism	0.000488	0.00535	CcSEcCtD
Pioglitazone—PTGS1—pituitary gland—hypothyroidism	0.000486	0.0126	CbGeAlD
Pioglitazone—CYP2C19—liver—hypothyroidism	0.00048	0.0124	CbGeAlD
Pioglitazone—CYP2C9—blood—hypothyroidism	0.000476	0.0123	CbGeAlD
Pioglitazone—Asthenia—Liotrix—hypothyroidism	0.000475	0.00521	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000472	0.0418	CbGpPWpGaD
Pioglitazone—Diarrhoea—Liotrix—hypothyroidism	0.000453	0.00497	CcSEcCtD
Pioglitazone—CYP2C8—testis—hypothyroidism	0.000443	0.0115	CbGeAlD
Pioglitazone—Dizziness—Liotrix—hypothyroidism	0.000438	0.0048	CcSEcCtD
Pioglitazone—PTGS1—adrenal gland—hypothyroidism	0.000435	0.0113	CbGeAlD
Pioglitazone—PTGS1—blood—hypothyroidism	0.000434	0.0113	CbGeAlD
Pioglitazone—PTGS1—thyroid gland—hypothyroidism	0.000419	0.0109	CbGeAlD
Pioglitazone—CYP2C8—liver—hypothyroidism	0.000419	0.0109	CbGeAlD
Pioglitazone—Headache—Liotrix—hypothyroidism	0.000415	0.00455	CcSEcCtD
Pioglitazone—PTGS1—female gonad—hypothyroidism	0.000405	0.0105	CbGeAlD
Pioglitazone—CYP2C9—liver—hypothyroidism	0.000372	0.00965	CbGeAlD
Pioglitazone—CYP3A4—blood—hypothyroidism	0.000363	0.00941	CbGeAlD
Pioglitazone—PTGS1—testis—hypothyroidism	0.000359	0.00931	CbGeAlD
Pioglitazone—CYP2D6—blood—hypothyroidism	0.000357	0.00926	CbGeAlD
Pioglitazone—CYP2D6—female gonad—hypothyroidism	0.000333	0.00863	CbGeAlD
Pioglitazone—CYP2D6—testis—hypothyroidism	0.000295	0.00766	CbGeAlD
Pioglitazone—CYP3A4—liver—hypothyroidism	0.000284	0.00736	CbGeAlD
Pioglitazone—CYP2D6—liver—hypothyroidism	0.000279	0.00724	CbGeAlD
Pioglitazone—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000279	0.0247	CbGpPWpGaD
Pioglitazone—CYP2D6—cerebellum—hypothyroidism	0.000273	0.00707	CbGeAlD
Pioglitazone—PPARG—Regulation of retinoblastoma protein—BGLAP—hypothyroidism	0.000233	0.0206	CbGpPWpGaD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.000226	0.02	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000196	0.0174	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00019	0.0168	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000187	0.0166	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000165	0.0146	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000158	0.0139	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000128	0.0113	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—THRA—hypothyroidism	0.000127	0.0112	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000106	0.00937	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	9.67e-05	0.00855	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—ZNF764—hypothyroidism	9.46e-05	0.00836	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—NKX2-5—hypothyroidism	9.02e-05	0.00798	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—THRB—hypothyroidism	8.16e-05	0.00721	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	8.01e-05	0.00708	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	7.61e-05	0.00672	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—CLTC—hypothyroidism	6.73e-05	0.00595	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—IYD—hypothyroidism	6.53e-05	0.00578	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.5e-05	0.00574	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—AVP—hypothyroidism	6.28e-05	0.00555	CbGpPWpGaD
Pioglitazone—PTGS1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.23e-05	0.00551	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—THRA—hypothyroidism	6.1e-05	0.00539	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—AVP—hypothyroidism	5.99e-05	0.00529	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—IGF1—hypothyroidism	5.69e-05	0.00503	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—IYD—hypothyroidism	5.57e-05	0.00493	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ATP5O—hypothyroidism	5.56e-05	0.00491	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.38e-05	0.00476	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—TPO—hypothyroidism	5.22e-05	0.00462	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.11e-05	0.00452	CbGpPWpGaD
Pioglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.97e-05	0.00439	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.84e-05	0.00428	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ATP5O—hypothyroidism	4.74e-05	0.00419	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—TPO—hypothyroidism	4.46e-05	0.00394	CbGpPWpGaD
Pioglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.43e-05	0.00392	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—IYD—hypothyroidism	4.39e-05	0.00388	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—NKX2-5—hypothyroidism	4.34e-05	0.00384	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.13e-05	0.00365	CbGpPWpGaD
Pioglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.08e-05	0.0036	CbGpPWpGaD
Pioglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.04e-05	0.00357	CbGpPWpGaD
Pioglitazone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.03e-05	0.00356	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.02e-05	0.00356	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—THRB—hypothyroidism	3.93e-05	0.00347	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—IYD—hypothyroidism	3.91e-05	0.00345	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.86e-05	0.00342	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ATP5O—hypothyroidism	3.73e-05	0.0033	CbGpPWpGaD
Pioglitazone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.59e-05	0.00318	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—TPO—hypothyroidism	3.51e-05	0.0031	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ATP5O—hypothyroidism	3.32e-05	0.00294	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—POMC—hypothyroidism	3.31e-05	0.00293	CbGpPWpGaD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.3e-05	0.00292	CbGpPWpGaD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.28e-05	0.0029	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.25e-05	0.00287	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—VAV3—hypothyroidism	3.17e-05	0.00281	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—TPO—hypothyroidism	3.12e-05	0.00276	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—AVP—hypothyroidism	3.04e-05	0.00269	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.89e-05	0.00256	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.67e-05	0.00236	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.6e-05	0.0023	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—IYD—hypothyroidism	2.52e-05	0.00223	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—TSHB—hypothyroidism	2.42e-05	0.00214	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—IYD—hypothyroidism	2.25e-05	0.00199	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.16e-05	0.00191	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3C2A—hypothyroidism	2.16e-05	0.00191	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ATP5O—hypothyroidism	2.14e-05	0.0019	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—POMC—hypothyroidism	2.14e-05	0.00189	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.13e-05	0.00188	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—IYD—hypothyroidism	2.07e-05	0.00183	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—TSHB—hypothyroidism	2.06e-05	0.00182	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—IYD—hypothyroidism	2.05e-05	0.00182	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.04e-05	0.00181	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TPO—hypothyroidism	2.02e-05	0.00178	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ATP5O—hypothyroidism	1.91e-05	0.00169	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—POMC—hypothyroidism	1.91e-05	0.00169	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.87e-05	0.00165	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3C2A—hypothyroidism	1.84e-05	0.00163	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.81e-05	0.0016	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—SLC5A5—hypothyroidism	1.81e-05	0.0016	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TPO—hypothyroidism	1.8e-05	0.00159	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ATP5O—hypothyroidism	1.76e-05	0.00156	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—POMC—hypothyroidism	1.76e-05	0.00155	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ATP5O—hypothyroidism	1.75e-05	0.00154	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—POMC—hypothyroidism	1.74e-05	0.00154	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.67e-05	0.00147	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TPO—hypothyroidism	1.66e-05	0.00146	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TPO—hypothyroidism	1.64e-05	0.00145	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—TSHB—hypothyroidism	1.62e-05	0.00144	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—SLC5A5—hypothyroidism	1.54e-05	0.00137	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.52e-05	0.00134	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	1.45e-05	0.00128	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—TSHB—hypothyroidism	1.45e-05	0.00128	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.43e-05	0.00126	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—IYD—hypothyroidism	1.35e-05	0.0012	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3C2A—hypothyroidism	1.29e-05	0.00114	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.27e-05	0.00112	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.22e-05	0.00108	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.15e-05	0.00102	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.15e-05	0.00101	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TPO—hypothyroidism	1.08e-05	0.000957	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SLC5A5—hypothyroidism	1.08e-05	0.000957	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—POMC—hypothyroidism	9.47e-06	0.000837	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TSHB—hypothyroidism	9.34e-06	0.000825	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TSHB—hypothyroidism	8.33e-06	0.000737	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	8.32e-06	0.000736	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.21e-06	0.000726	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—POMC—hypothyroidism	8.08e-06	0.000714	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TSHB—hypothyroidism	7.66e-06	0.000678	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TSHB—hypothyroidism	7.6e-06	0.000672	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	7.43e-06	0.000657	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.33e-06	0.000648	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC5A5—hypothyroidism	6.99e-06	0.000618	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	6.83e-06	0.000604	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	6.77e-06	0.000599	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.68e-06	0.000591	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—POMC—hypothyroidism	6.36e-06	0.000563	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC5A5—hypothyroidism	6.24e-06	0.000552	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC5A5—hypothyroidism	5.74e-06	0.000507	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC5A5—hypothyroidism	5.69e-06	0.000503	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—POMC—hypothyroidism	5.66e-06	0.000501	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TSHB—hypothyroidism	5.01e-06	0.000443	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	4.47e-06	0.000395	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.75e-06	0.000332	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—POMC—hypothyroidism	3.66e-06	0.000323	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—POMC—hypothyroidism	3.26e-06	0.000289	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—POMC—hypothyroidism	3e-06	0.000265	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—POMC—hypothyroidism	2.98e-06	0.000263	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—POMC—hypothyroidism	1.96e-06	0.000174	CbGpPWpGaD
